BCB
Brian C. Broderick Portfolio holdings
AUM
$506M
This Quarter Return
+7.37%
1 Year Return
+12.39%
3 Year Return
+70.69%
5 Year Return
+110.99%
10 Year Return
+270.67%
AUM
$379M
AUM Growth
+$379M
(+6.4%)
Cap. Flow
-$1.02M
Cap. Flow
% of AUM
-0.27%
Top 10 Holdings %
Top 10 Hldgs %
40.31%
Holding
81
New
1
Increased
16
Reduced
34
Closed
–
Top Buys
| 1 |
Airbnb
ABNB
|
$502K |
| 2 |
Nike
NKE
|
$473K |
| 3 |
UnitedHealth
UNH
|
$331K |
| 4 |
Aptiv
APTV
|
$277K |
| 5 |
Medtronic
MDT
|
$252K |
Top Sells
| 1 |
NVIDIA
NVDA
|
$1.57M |
| 2 |
Apple
AAPL
|
$310K |
| 3 |
Procter & Gamble
PG
|
$150K |
| 4 |
Microsoft
MSFT
|
$141K |
| 5 |
Honeywell
HON
|
$123K |
Sector Composition
| 1 | Technology | 28.44% |
| 2 | Healthcare | 19.02% |
| 3 | Industrials | 13.9% |
| 4 | Consumer Discretionary | 7.99% |
| 5 | Consumer Staples | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
PepsiCo
PEP
$203B
| $4.27M | 1.13% |
23,055
-200
| -0.9% | -$37K |
|
27
Chevron
CVX
$318B
| $4.01M | 1.06% |
25,512
-95
| -0.4% | -$14.9K |
|
28
Exxon Mobil
XOM
$477B
| $3.79M | 1% |
35,373
-540
| -2% | -$57.9K |
|
|
29
Nike
NKE
$110B
| $3.32M | 0.88% |
30,121
+4,282
| +17% | +$473K |
|
30
Church & Dwight Co
CHD
$22.7B
| $2.89M | 0.76% |
28,800
| – | – |
|
31
Novartis
NVS
$248B
| $2.78M | 0.73% |
27,590
-360
| -1% | -$36.3K |
|
32
PayPal
PYPL
$66.5B
| $2.49M | 0.66% |
37,330
-1,250
| -3% | -$83.4K |
|
33
Illumina
ILMN
$15.2B
| $2.42M | 0.64% |
12,918
+25
| +0.2% | +$4.74K |
|
|
34
Medtronic
MDT
$118B
| $2.38M | 0.63% |
26,986
+2,858
| +12% | +$252K |
|
35
AbbVie
ABBV
$374B
| $1.65M | 0.44% |
12,267
| – | – |
|
|
36
Aptiv
APTV
$17.3B
| $1.58M | 0.42% |
15,512
+2,715
| +21% | +$277K |
|
37
SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$11B
| $1.58M | 0.42% |
29,000
-1,000
| -3% | -$54.4K |
|
38
Welltower
WELL
$112B
| $1.5M | 0.39% |
18,500
| – | – |
|
39
Edwards Lifesciences
EW
$47.7B
| $1.04M | 0.27% |
11,000
+1,650
| +18% | +$156K |
|
40
Becton Dickinson
BDX
$54.3B
| $850K | 0.22% |
3,218
+245
| +8% | +$64.7K |
|
41
Trane Technologies
TT
$90.9B
| $759K | 0.2% |
3,970
| – | – |
|
42
Bristol-Myers Squibb
BMY
$96.7B
| $748K | 0.2% |
11,700
| – | – |
|
43
Merck
MRK
$210B
| $707K | 0.19% |
6,125
-25
| -0.4% | -$2.89K |
|
44
Novo Nordisk
NVO
$252B
| $697K | 0.18% |
4,310
-100
| -2% | -$16.2K |
|
45
Walt Disney
DIS
$211B
| $689K | 0.18% |
7,717
+175
| +2% | +$15.6K |
|
46
Pembina Pipeline
PBA
$21.9B
| $689K | 0.18% |
21,901
| – | – |
|
47
Moderna
MRNA
$9.36B
| $583K | 0.15% |
4,800
| – | – |
|
48
HubSpot
HUBS
$24.9B
| $532K | 0.14% |
1,000
| – | – |
|
49
Thermo Fisher Scientific
TMO
$183B
| $511K | 0.13% |
980
| – | – |
|
|
50
Airbnb
ABNB
$76.5B
| $502K | 0.13% |
+3,920
| New | +$502K |
|